Thoracic perfusion of antiangiogenic agents combined with chemotherapy for treating malignant pleural effusion in non-small cell lung cancer: a network meta-analysis
Objectives Different intrathoracic perfusion therapeutic regimens are available for non-small cell lung cancer with malignant pleural effusion (MPE). Antiangiogenic agents are often used to control MPE, and the results are satisfactory. Here, we performed a network meta-analysis to reveal optimal co...
Saved in:
Main Authors: | Yan Xu, Wei Si, Yingying Cui, Liming Jiang, Yinan Yu, Xiaohua Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-12-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/12/e080703.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Malignant Pleural Effusion: Diagnosis and Management
by: Lucía Ferreiro, et al.
Published: (2020-01-01) -
Management of Malignant Pleural Effusions with Indwelling Pleural Catheters or Talc Pleurodesis
by: Nadim Srour, et al.
Published: (2013-01-01) -
Identifying malignant pleural effusion from tubercular pleural effusion by study of cancer ratio and cancer ratio plus
by: Subhankar Saren, et al.
Published: (2025-02-01) -
The presence of pleural effusion is an independent prognostic factor in patients with malignant pleural mesothelioma
by: Haoyu Wang, et al.
Published: (2025-01-01) -
The Safety and Efficacy of Chemical Pleurodesis Agents in Patients with Malignant Pleural Effusion Admitted in Tertiary Care Hospital
by: Venkateshwaran Kathamuthu, et al.
Published: (2025-01-01)